Our study demonstrates that level of AR-V7 increased abnormally with increase in ABCC5 expression via the activation of the NF-κB pathway in CPRC tissue and enzalutamide-resistant PCa cells. The gene discussed is ABCC5; the disease is posterior cortical atrophy.